Biolife Solutions (BLFS) Total Non-Current Liabilities (2016 - 2025)
Biolife Solutions (BLFS) has disclosed Total Non-Current Liabilities for 16 consecutive years, with $33.8 million as the latest value for Q4 2025.
- On a quarterly basis, Total Non-Current Liabilities fell 33.12% to $33.8 million in Q4 2025 year-over-year; TTM through Dec 2025 was $33.8 million, a 33.12% decrease, with the full-year FY2025 number at $33.8 million, down 33.12% from a year prior.
- Total Non-Current Liabilities was $33.8 million for Q4 2025 at Biolife Solutions, down from $50.6 million in the prior quarter.
- In the past five years, Total Non-Current Liabilities ranged from a high of $88.4 million in Q1 2023 to a low of $27.0 million in Q1 2021.
- A 5-year average of $66.3 million and a median of $71.8 million in 2021 define the central range for Total Non-Current Liabilities.
- Peak YoY movement for Total Non-Current Liabilities: soared 786.83% in 2021, then crashed 33.12% in 2025.
- Biolife Solutions' Total Non-Current Liabilities stood at $76.2 million in 2021, then increased by 9.88% to $83.7 million in 2022, then fell by 10.36% to $75.1 million in 2023, then tumbled by 32.61% to $50.6 million in 2024, then crashed by 33.12% to $33.8 million in 2025.
- Per Business Quant, the three most recent readings for BLFS's Total Non-Current Liabilities are $33.8 million (Q4 2025), $50.6 million (Q4 2024), and $75.1 million (Q4 2023).